Prime 10 Free On-line Programs in Q1 2023
MyCME, the chief in free medical schooling, provides a bunch of programs throughout all cardiovascular illnesses. Entry the complete library of Cardiology CME and CE free of charge.
The highest cardiology CME programs out there now on www.myCME.com embody matters on mitral stenosis, anemia, cardiac arrhythmia, and extra.
Program Description
Moderated by James A. Underberg, MD, MS, FACP, FNLA and that includes a panel with 4 school audio system (Linda Hemphill, MD, FACC, FNLA, FAHA, Robert Rosenson, MD, Seth Martin, MD, MHS, and Luba Burchett, RN, BSN) this 60 minute webcast will cowl the next data: epidemiology of homozygous familial hypercholesterolemia (HoFH), indicators and signs, prognosis and identification of sufferers with HoFH, screening and genetic assessments, at present out there therapy choices for sufferers, present tips for therapy, expertise with evinacumab, navigating the therapy of ladies and kids, and potential boundaries to therapy.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Determine the indicators, signs, and diagnostic markers of familial hypercholesterolemia
- Describe present tips for the therapy of homozygous familial hypercholesterolemia (HoFH)
- Examine and distinction present therapy choices for HoFH
- Formulate care methods that incorporate affected person wants and potential boundaries to therapy
Meant Viewers
Cardiologists, lipidologists, internists, main care suppliers, infusion heart nurses, and different healthcare suppliers who deal with sufferers with HoFH.
Business Supporter
This exercise is supported by an academic grant from Regeneron Prescribed drugs.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ANCC Contact Hour
Expires: April 14, 2023
Program Description
Dr. Tsuyoshi Kaneko lends an skilled perspective on the quickly rising proof base on the position of transcatheter aortic valve alternative (TAVR) in sufferers with bicuspid valve anatomy, together with the latest knowledge introduced on the 2022 annual assembly of the Society of Thoracic Surgeons (STS). Whereas outcomes can rival these seen with conventional surgical valve alternative, Dr. Kaneko notes necessary caveats relating to correct affected person choice that underscore the necessity for evaluation by a coronary heart valve workforce when deciding between the 2 approaches.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Summarize the findings of latest knowledge registry analyses in sufferers with bicuspid aortic valves who’ve undergone both surgical or transcatheter aortic valve alternative (SAVR or TAVR)
- Apply these knowledge to the identification of sufferers with bicuspid valve anatomy who would profit from analysis by a coronary heart valve workforce
Meant Viewers
The audience for this exercise is members of the guts valve workforce, together with referring/group cardiologists, interventional cardiologists, and cardiothoracic surgeons, in addition to main care physicians, nurses, nurse practitioners, doctor associates, and others who take care of sufferers with aortic stenosis and bicuspid anatomy.
Business Supporter
Supported by an academic grant from Edwards Lifesciences.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score(s)
- 0.50 / ANCC Contact Hour(s)
Expires: April 15, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) is an under-recognized, frequent, and treatable genetic illness occurring worldwide. HCM is a myocardial dysfunction most frequently brought on by mutations in certainly one of a number of sarcomere genes that encode elements of the contractile equipment of the guts. It’s characterised by ventricular hypertrophy that can’t be defined by one other cardiac or systemic illness. Including to the burden of illness, HCM can current with a wide range of signs mimicking different circumstances and will go undiagnosed for a few years and it’s estimated that roughly one in 500 people in america might have clinically unrecognized, undiagnosed HCM, with an general prevalence estimated at 750,000.
Please be a part of Dr. Maron and Dr. Torres on this first installment of a CMEO Snack sequence as they focus on methods for optimum screening of HCM in an effort to extend recognition and prognosis of this too usually misdiagnosed illness.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Assess security and efficacy of rising brokers.
Meant Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Major care physicians/Normal practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Business Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) generally is a persistent, progressive situation during which sufferers expertise signs of dyspnea, dizziness, and fatigue in addition to critical problems equivalent to coronary heart failure, arrhythmias, stroke, and sudden cardiac dying. HCM is a masquerading illness and is definitely confused with different circumstances. As a result of there are lots of totally different symptomatic manifestations of HCM, clinicians usually are not all the time updated with evidence-based therapy suggestions, lacking alternatives to supply aid to sufferers with HCM. Follow tips for HCM launched in December 2020 by the AHA/ACC present additional element on when to make use of out there therapy choices. Clinicians want to remain present on the most recent suggestions to organize to deal with or refer sufferers with HCM to a specialist.
Be part of Drs. Maron and Olivotto on this 2nd installment of a 3-part CMEO Snack sequence on HCM as they establish methods for clinicians to higher implement international and country-specific guideline suggestions to enhance take care of sufferers with HCM.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Assess security and efficacy of rising brokers.
Meant Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Major care physicians/Normal practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Business Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Hypertrophic cardiomyopathy (HCM) is prevalent around the globe, with a conservatively estimated 20 million people affected. Even in developed international locations, present administration of HCM is suboptimal. A lot has been realized over the previous 2 many years in regards to the pathophysiology of HCM and new therapies equivalent to mavacamten, CK-274, IMB-101, and CT-G20 are at present being developed and examined in medical trials addressing the underlying pathophysiology of HCM. Though these new brokers are in late phases of improvement, clinicians are sometimes not absolutely updated on this progress and the potential alternative to enhance take care of sufferers.
Please be a part of Drs. Maron and Rakowski on this remaining installment of a CMEO Snack sequence on HCM as they focus on strategies to evaluate examine outcomes of rising HCM disease-specific remedies concentrating on cardiac myosin with a view to optimize outcomes for sufferers.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Assess examine outcomes of rising HCM disease-specific remedies relating to cardiac myosin.
Meant Viewers
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons (Secondary: Major care physicians/Normal practitioners, PAs, nurse practitioners, nurses, and pharmacists).
Business Supporter
Supported by an academic grant from Bristol Myers Squibb.
Max Credit
- 0.50 / AMA PRA Class 1 Credit score
- 0.50 / ABIM MOC Level
- 0.50 / AAPA Class 1 CME Credit score
- 0.50 / ANCC Contact Hour
- 0.50 / CE for Pharmacists
Expires: Might 10, 2023
Program Description
Remedy tips embody suggestions on just lately authorized medicines and discussions of latest medical trial knowledge on monotherapy and mixture therapy choices for pulmonary arterial hypertension (PAH). Present and rising administration methods goal new pathways and therapy targets. This foundational exercise supplies nurses with a high-level overview of therapy pathways and therapeutic targets for the administration of PAH.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Assessment the pathophysiology, diagnostic standards, and classification of PAH.
- Determine the courses and related unintended effects of medicines used to deal with PAH.
- Summarize new therapy pathways and rising therapeutic targets within the administration of PAH.
- Acknowledge the potential for distant monitoring by way of telehealth in sufferers with PAH.
Meant Viewers
The meant viewers contains nurse practitioners, nurses, doctor assistants and different suppliers concerned within the administration of sufferers with PAH.
Business Supporter
This exercise is supported by an unbiased medical schooling grant from Actelion Prescribed drugs US, Inc., a Janssen Pharmaceutical Firm of Johnson & Johnson.
Max Credit
- 1.00 / AAPA Class 1 CME Credit score
- 1.00 / AANP Contact Hour
- 1.00 / ANCC Contact Hour
Expires: Might 14, 2023
Program Description
On this GapEd Webcast, skilled school audio system Naushira Pandya and Meenakshi Patel will illustrate by way of affected person instances the significance of individualized A1C objectives and methods on methods to optimize glycemic management whereas simplifying regimens, minimizing hypoglycemia threat, and bettering interdisciplinary communication. Via this gap-based exercise, learners will be capable to skip content material they know nicely and think about content material that’s contemplate important by the school, or they’ve a demonstrated hole in data.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Individualize A1C objectives primarily based on patient- and disease-specific components
- Examine and distinction fix-ratio combos of GLP-1 RA plus basal insulin with different insulin regimens
- Devise glucose decreasing regimens that optimizes high quality of life and glucose management and minimizes hypoglycemia
- Implement methods to enhance interdisciplinary communication and facility care processes to optimize diabetes outcomes
Meant Viewers
Major Care Physicians, Diabetologists, Endocrinologists, Household Follow Physicians, Household Follow/Normal Follow Physicians, Normal Follow Physicians, Geriatric Drugs Physicians, Inner Drugs Physicians, Managed Care, Nurse Practitioners, Doctor Assistants, Different healthcare professionals who deal with sufferers with diabetes in a long-term care facility
Business Supporter
This exercise is supported by an academic grant from Sanofi US.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
Expires: Might 15, 2023
Program Description
Dr. Gregory Serrao from Mount Sinai discusses antiplatelet considerations and pharmacodynamics within the context of cardiogenic shock. Subsequent, evaluate the trial knowledge, indications, and contraindications on cangrelor introduced by Dr. Jennifer Rymer, MD, from Duke Well being. Moreover, you’ll perceive the optimum “recipe” for antiplatelet administration in HR NSTEMI, STEMI, and cardiogenic shock. Lastly, view a case centered on antiplatelet remedy with cardiogenic shock.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Look at the pharmacokinetic/pharmacodynamic profile of parenteral antiplatelet brokers
- Assessment present knowledge on antiplatelet issues in acute coronary syndrome (ACS) and cardiogenic shock
- Describe modern antiplatelet therapy protocols in ST-elevation myocardial infarction (STEMI) and cardiogenic shock
- Talk about future antiplatelet and antithrombotic therapeutic targets
Meant Viewers
Cardiologists
Business Supporter
This exercise is supported by an unrestricted academic grant from Chiesi.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ABIM MOC Level
Expires: Might 30, 2023
Program Description
Assessment Proper-Sided mechanical circulatory help (MCS) with RA-PA Pump and Left-Sided MCS with LA-AO Pump. Be taught extra in regards to the rising position of VA ECMO within the cath lab from Dr. Emmanouil Brilakis. Talk about an summary of biventricular MCS with LA-AO and RA-PA pumps from Dr. Khaldoon Alaswad with Henry Ford Well being and apply the knowledge with a case presentation. Dr. Daniel Burkhoff from CRF and Dr. Rajan Patel reasonable a full of life dialogue.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Assess the implications of proper ventricular (RV) failure in cardiogenic shock
- Talk about the advantages of left atrial-aorta (LA-AO) and proper atrial-pulmonary artery (RA-PA) MCS programs
- Describe the position of biventricular MCS in treating cardiogenic shock
Meant Viewers
Cardiologists, Emergency Care Physicians, Hospitalists
Business Supporter
This exercise is supported by an academic grant from LivaNova.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score
- 1.00 / ABIM MOC Level
Expires: Might 30, 2023
Program Description
Mild chain (AL) amyloidosis, a uncommon clonal plasma cell dysfunction characterised by organ deposition of amyloid protein, leads to progressive organ injury that’s often irreversible. Immediate therapy is vital to attaining the very best outcomes, however speedy initiation of therapy requires early, correct prognosis, which is commonly delayed due to the nonspecific nature of the signs. Sadly, delayed prognosis is a grave concern, because the median survival fee amongst some untreated sufferers is roughly 6 months following symptom onset.
A excessive index of suspicion and applicable testing are wanted to make a prognosis of AL amyloidosis, however the vital delays and a number of doctor visits sufferers sometimes encounter (many sufferers report seeing no less than 5 physicians, together with cardiologists and nephrologists, earlier than receiving a prognosis) point out that clinicians proceed to be confounded by this situation’s extremely variable medical presentation.
Therapies for AL amyloidosis goal the aberrant plasma/B-cell clone and have historically been primarily based on regimens tailored from the increasing therapy choices out there for a number of myeloma; nonetheless, in January 2021 the FDA authorized a remedy particularly to be used in sufferers with AL amyloidosis.
This exercise includes a roundtable dialogue with a multidisciplinary panel of consultants on the most recent data on evidence-based prognosis and therapy tips for sufferers with AL amyloidosis.
Instructional Targets
Upon completion, contributors ought to be capable to:
- Acknowledge the medical shows that ought to elevate suspicion of AL amyloidosis
- Make the most of optimum diagnostic testing to attenuate delays in therapy initiation
- Define present and rising therapy choices which might be out there to deal with sufferers with AL amyloidosis, utilizing supporting medical trial knowledge
Meant Viewers
This exercise is designed to satisfy the tutorial wants of hematologist-oncologists, medical oncologists, oncology nurses, cardiologists, nephrologists, and different well being care suppliers concerned within the prognosis and therapy of sufferers with AL amyloidosis.
Business Supporter
This exercise is supported by academic grants from The Binding Website and Janssen Biotech Inc., administered by Janssen Scientific Affairs, LLC.
Max Credit
- 1.00 / AMA PRA Class 1 Credit score(s)
- 1.00 / ABIM MOC Half II Factors
- 1.00 / CNE Contact Hour(s)
Expires: June 6, 2023
The Cardiology Advisor Institute, powered by myCme, is a specialty-based group providing cardiology CE and CME programs, sources, and information tailor-made and curated for you. Specialised matters embody these and extra:
- Homozygous familial hypercholesterolemia (HoFH)
- Mineralocorticoid receptor antagonists
- Hypertrophic cardiomyopathy (HCM)
- Atrial fibrillation and AFIB therapy
- Excessive-sensitivity cardiac troponin (hs-cTn)
- Transcatheter aortic valve alternative (TAVR)
Be certain that to benefit from this catalog of accredited free cardiology CE and CME programs on your persevering with schooling.
